Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series

K-Number: K182397 · 2018-12-13

Decision Date2018-12-13
Product CodeMCW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series is a medical device manufactured by Cardiovascular Systems, Inc.. It received FDA 510(k) clearance on 2018-12-13 under approval number K182397. The device is classified under product code MCW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series?

Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series is a medical device that received FDA 510(k) clearance on 2018-12-13. It is manufactured by Cardiovascular Systems, Inc.. The 510(k) number is K182397.

When was Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series approved by the FDA?

Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series received FDA 510(k) clearance on 2018-12-13, under approval number K182397.

What company makes Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series?

Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series is manufactured by Cardiovascular Systems, Inc..

What is the FDA product code for Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series?

The FDA product code for Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series is MCW.

Related Clinical Trials

Related PubMed Literature

Other Devices by Cardiovascular Systems, Inc.

View all 14 devices →

Related Devices (Code: MCW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.